Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.56 USD | +17.13% | +9.48% | +90.79% |
04:39pm | Agios Says of Trial of Blood Disorder Drug Mitapivat Met Primary Endpoint; Shares Rise | MT |
02:00pm | Transcript : Agios Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+90.79% | 2.06B | |
+14.28% | 118B | |
+12.94% | 106B | |
-3.62% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.01% | 15.56B | |
+4.22% | 13.63B | |
+27.59% | 12.27B |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- Earnings Flash (AGIO) AGIOS PHARMACEUTICALS Posts Q1 Revenue $5.6M